Patient Profile 1: A Patient With HER2+ Metastatic BC Treated With T-DXd who Develops ILD


After reviewing the historical use of ADCs, panelists discuss the first patient profile of HER2+ metastatic breast cancer managed with trastuzumab deruxtecan.

Related Videos
Pattie Jakel
Christine Wylie
Karyn Goodman
Grace Choong
Ahulwalia on Targeting the Blood Brain Barrier With Novel Immunotherapies and Precision Oncology
Expert in oncology
Expert in oncology
Related Content
© 2024 MJH Life Sciences

All rights reserved.